FDA Adverse Event Injury Summary report: N

DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM

MDR report key: 19001242 · Received March 28, 2024

Report

Report Number
3004753838-2024-073353
Event Type
Injury
Date Received
March 28, 2024
Date of Event
March 2, 2024
Report Date
April 2, 2024
Manufacturer
DEXCOM, INC.
Product Code
QBJ
PMA / PMN Number
K213919
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

(B)(4).

Additional Manufacturer Narrative · 0

(B)(4). DIABETES MELLITUS IS A KNOWN CAUSE OF HYPOGLYCEMIA AND LOSS OF CONSCIOUSNESS. H6 MEDICAL DEVICE PROBLEM CODE - 3191 - PATIENT WAS UNABLE TO IDENTIFY DEVICE ISSUE THEREFORE A MORE SPECIFIC CODE COULD NOT BE SELECTED.

Description of Event or Problem · 0

SUBSEQUENT TO THE INITIAL MDR, A CORRECTION WAS UPDATED ON 3/29/2024.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT EXPERIENCED A HYPOGLYCEMIC EVENT WHILE USING A DIABELOOP DBLG1 CLOSED-LOOP SYSTEM, WHICH OCCURRED 6 DAYS AFTER THE SENSOR WAS INSERTED IN THE ARM. ON (B)(6) 2024, THE DAY OF THE EVENT, THE PATIENT RECEIVED A WARNING ON THE DBLG1 SYSTEM BUT WAS UNABLE TO REMEMBER WHAT TYPE OF WARNING IT WAS. AT AN UNKNOWN TIME AFTER THIS THE PATIENT LOST CONSCIOUSNESS. AN AMBULANCE WAS CALLED BY THE PATIENT´S HUSBAND AND WHEN THE PARAMEDICS ARRIVED A FINGERSTICK WAS TAKEN AND THE BLOOD GLUCOSE READING WAS 42 MG/DL, IT IS NOT KNOWN WHAT THE CGM (CONTINUOUS GLUCOSE MONITOR) DEVICE WAS DISPLAYING AT THAT MOMENT. THE PATIENT WAS GIVEN INTRAVENOUS TREATMENT WITH GLUCOSE. IT WAS NOT REPORTED THAT MORE TREATMENT WAS NEEDED, AND IT WAS STATED THAT THE PATIENT DID NOT NEED TO GO TO THE HOSPITAL. THERE WAS NO DOCUMENTATION OF FURTHER MEDICAL EVALUATION OR INTERVENTION. AT THE TIME OF THE REPORT THE PATIENT WAS STABLE. NO OTHER DETAILS WERE DOCUMENTED, AND THE PATIENT DID NOT REMEMBER MORE DETAILS REGARDING THE EVENT. DATA WAS EVALUATED AND THE ALLEGATION WAS UNDETERMINED. A REVIEW OF PERFORMANCE DATA SHOWS THAT THE PATIENT DID NOT EXPERIENCE ANY SIGNIFICANT OR LONG-TERM ISSUE THAT WOULD HAVE CAUSED A DISRUPTION IN HER CGM READINGS ON OR AROUND THE ALLEGED ISSUE DATE OF (B)(6) 2024. DATA INVESTIGATION ALSO SHOWS THAT THE PATIENT'S EGVS (ESTIMATED GLUCOSE VALUE) DID NOT DROP LOWER THAN 84 MG/DL AT ANY POINT ON THIS DAY. MOREOVER, DURING THE ALLEGED TIME OF THE INCIDENT AT 1:00 PM, THE PATIENT'S ESTIMATED GLUCOSE VALUES WERE OBSERVED TO BE READING AROUND 100 MG/DL DESPITE THE PATIENT HAVING ALLEGED A BLOOD GLUCOSE METER VALUE OF LESS THAN 42 MG/DL. THUS, INACCURATE ESTIMATED GLUCOSE VALUES HAVE BEEN DETERMINED TO BE THE MOST LIKELY THE ROOT CAUSE OF THE HYPOGLYCEMIC EVENT. NO OTHER PATIENT OR EVENT DETAILS WERE AVAILABLE AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2253705 DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM CONTINUOUS GLUCOSE MONITOR QBJ DEXCOM, INC. 9500-161 1723323001

Patients

Seq Age Sex Outcome Treatment
1 66 YR Female Other DIABELOOP DBLG1 CLOSED-LOOP SYSTEM